What Medications Cause Hair Loss?

Reviewed by Dr. Emin Gül · Reviewed in accordance with our Editorial Standards.

Medications that cause hair loss include chemotherapy drugs, anticoagulants, and beta-blockers. The treatments interfere with the normal hair cycle, damaging the follicle or forcing it into a resting phase. The most common types of drug-induced alopecia are telogen effluvium and anagen effluvium, depending on how the medication affects the growth phase.

Medications that cause hair loss affect the body by disrupting hormone levels, blocking nutrient absorption, altering blood flow to follicles, or damaging dividing cells. Drugs that cause hair loss (paclitaxel and cyclophosphamide) target rapidly dividing cancer cells but harm hair-producing cells in the process. Medicines that cause hair loss (metoprolol or isotretinoin) interfere with follicle stability through hormonal or metabolic changes. Factors (dosage, treatment duration, and individual sensitivity) determine how severe the hair loss becomes. Recognizing the specific drugs that cause hair loss is critical for adjusting treatment or applying protective solutions.

What Are the Types o Medications that Causes Hair Loss?

The Types of Medications that cause hair Loss are listed below. 

• Chemotherapy drugs: Chemotherapy attacks fast-growing cells, including hair follicles, which causes sudden and widespread hair loss. Drugs (cyclophosphamide, doxorubicin, and paclitaxel) are well-known for their effect. Adults are equally at risk, but children regrow hair faster post-treatment.
• Anticoagulants (blood thinners): Medications (warfarin and heparin) cause hair to enter the shedding phase early. It leads to diffuse thinning rather than patches of baldness. Hair loss risk is higher in adults, and long-term use increases the chances in sexes (females and males).
• Beta-blockers: Used for blood pressure and heart problems, beta-blockers (metoprolol and propranolol) interrupt the hair growth cycle. Blockers shift more follicles into the resting phase (telogen), leading to shedding. Hair loss tends to be more common in older adults, with no major difference between men and women.
• Retinoids (Vitamin A derivatives): High doses of retinoids (isotretinoin) disrupt hair follicle health by affecting skin cell turnover and oil production. It causes dryness of the scalp and hair thinning. Young adults treated for acne show higher sensitivity.
• Antidepressants: Selective Serotonin Reuptake Inhibitors (SSRIs) and tricyclics (fluoxetine and amitriptyline) have been linked to telogen effluvium, a form of diffuse hair loss. The drugs affect serotonin levels that indirectly influence hair follicles. Women seem to report hair loss from antidepressants more than men.
• Anticonvulsants (seizure medications): Drugs (valproic acid and carbamazepine) interfere with nutrient absorption and hormone levels that support hair health. Hair loss is gradual and reversible. Children are more sensitive to the effects due to developing systems.
• Immunosuppressants: Drugs (cyclosporine and methotrexate) weaken follicle growth, used after organ transplants or for autoimmune diseases. The drugs affect the immune system’s ability to maintain healthy skin and hair. Hair loss risk is shared in age groups, but long-term users face higher chances.
• Thyroid medications: Overdosing on levothyroxine or other thyroid hormones mimics symptoms of hyperthyroidism, including hair thinning. Hair follicles respond to hormone imbalance by shedding early. Women and older adults are more affected due to higher rates of thyroid disorders.
• Cholesterol-lowering drugs (statins): Statins (atorvastatin) reduce hair protein formation by interfering with cholesterol synthesis. Hair thins slowly over time with long-term use. Hair loss risk is higher in adults, with no strong gender difference.
• Hormonal medications: Birth control pills, hormone replacement therapy, and anabolic steroids disrupt the body’s hormone balance, which controls hair growth and shedding. Medications (drospirenone, levonorgestrel, and testosterone) supplements trigger androgenetic alopecia in sensitive patients. A research “Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics” by MS Nestor, G Ablon, A Gade, & H Han 2021 found that hormone-based drugs impact hair cycles in women using contraceptives.

Higher dosages increase the risk of hair loss because they affect more of the body’s systems, including hair growth cycles. Long-term or high-dose users are experiencing thinning or shedding. Sticking to the lowest effective dose helps reduce the side effects. 

Why Do Chemotherapy Drugs Cause Hair Loss?

Chemotherapy drugs cause hair loss because they target dividing cells, including follicles, leading to a condition known as anagen effluvium. Cytotoxic agents disrupt the mitotic activity of matrix keratinocytes in the hair bulb, impairing the structural integrity of the hair shaft. The cytostatic action fragments the deoxyribonucleic acid (DNA) of proliferating follicular cells, initiating premature follicle regression and shaft breakage at the scalp surface. Alopecia severity depends on the agent’s dosage, administration route, and cumulative exposure. Alkylating agents and antimicrotubule agents (cyclophosphamide, doxorubicin, paclitaxel, docetaxel) exhibit the highest rates of alopecia, causing complete scalp hair loss within 7 to 14 days of the first cycle.

Anthracyclines and taxanes are the most consistent in inducing total alopecia among all chemotherapeutics. Anthracyclines (doxorubicin, epirubicin) intercalate DNA and generate free radicals, while taxanes (docetaxel, paclitaxel) stabilize microtubules and inhibit depolymerization, disrupting mitotic spindle formation in follicular cells. Over 80% of patients receiving combination regimens with anthracyclines and taxanes experienced grade III-IV alopecia, classified by the Common Terminology Criteria for Adverse Events (CTCAE). According to “Management of chemotherapy-induced alopecia: a retrospective study” by H. Trueb 2018. The psychological burden of chemotherapy-induced alopecia necessitates proactive patient counseling and potential interventions. 

Why Antibiotics Make Your Hair Fall Out?

Antibiotics make your hair fall out because they disrupt the gut microbiota, impair nutrient absorption, and trigger telogen effluvium by altering systemic immune responses. Antibiotic-induced dysbiosis reduces levels of biotin, zinc, and other micronutrients essential for keratinocyte proliferation in the anagen phase. Prolonged exposure activates inflammatory pathways that elevate tumor necrosis factor-alpha (TNF-α), which negatively affect follicular cycling. Hair follicles prematurely shift from anagen to telogen phase, resulting in diffuse hair shedding 2 to 3 months post-exposure. The impact is compounded in cases of hypersensitivity reactions, where immune complexes target follicular units.

Fluoroquinolones (ciprofloxacin, levofloxacin), tetracyclines (doxycycline, minocycline), and penicillin derivatives (amoxicillin, ampicillin) are most associated with antibiotics hair loss. Amoxicillin hair loss is transient and reversible, yet recurrent use amplifies follicular stress. Antibiotic-related alopecia represented 12% of drug-induced hair loss cases in dermatological records, according to “Adverse drug reactions affecting hair: Review” by Patel and Sharma 2013. Antibiotics interfere with mitochondrial activity and generate reactive oxygen species (ROS), leading to oxidative damage in follicular stem cells and eventual shedding.

Why Do Blood Pressure Medications Cause Hair Loss?

Blood pressure medications cause hair loss because beta‑adrenergic blockade and angiotensin‑converting enzyme (ACE) inhibition provoke premature follicular transition into the telogen (resting) phase, inducing telogen effluvium. Metoprolol’s high lipophilicity facilitates penetration into the blood and brain barrier, suppressing sympathetic‑mediated signals essential for follicular cycling and reducing renin-angiotensin-aldosterone axis function. Lisinopril inhibits ACE, diminishing angiotensin II production, which regulates vascular perfusion and aldosterone secretion, essential for nutrient delivery to hair follicles. Rare cases of metoprolol hair loss and propranolol hair loss have been reported. High blood pressure and hair loss reflect the pharmacodynamic disruptions.

Telogen effluvium onset associated with metoprolol hair loss occurs at therapeutic oral doses (50–200 mg/day). Lisinopril hair loss appears at standard doses (10-40 mg/day), but incidence remains below 1% in controlled trials. Hair shedding resolves upon discontinuation, with full regrowth in most subjects. Irreversible alopecia is not documented in association with the agents. Telogen effluvium associated with beta‑blockers (metoprolol) and ACE inhibitors (lisinopril) remains uncommon. Reversible once drug exposure ceases, according to Medications that Can Cause Hair Loss, the Blood Pressure Medications section by Verywell Health 2024.

How Do Weight Loss Medications Cause Hair Loss?

Weight loss medications cause hair loss through metabolic stress, nutrient depletion, and abrupt weight reduction that trigger telogen effluvium. Appetite‑suppressant agents reduce the intake of proteins, iron, zinc, and vitamins essential for follicular keratinocyte proliferation in the anagen growth phase. Rapid decline in body mass shifts a higher percentage of follicles prematurely into the telogen (resting) phase, causing noticeable hair shedding 3-4 weeks later. Hormonal fluctuations and oxidative stress linked to caloric restriction compound follicular vulnerability.

The prevalence of hair loss remains low among weight loss drugs. Phentermine hair loss arises indirectly through appetite suppression‑induced nutrient deficiency and metabolic strain rather than direct folliculotoxicity. Hair shedding resolves upon weight stabilization, regrowth is expected within 3 to 6 months, indicating non‑permanent telogen effluvium.  Zepbound hair loss observed in clinical trials reaches 4 to 5% of users, with a higher incidence in females versus males. Severity correlates with dose magnitude and rate of weight loss. Semaglutide usage conveyed a 50% elevated risk of alopecia relative to placebo controls, with women facing double compared to men, according to “Risk of Hair Loss with Semaglutide for Weight Loss” 2025. Analysis by the University of British Columbia.

How Can Medications Cause Hair Loss?

Medications cause hair loss through interference with the natural hair growth cycle, which includes a growing phase (anagen), resting phase (telogen), and shedding phase (exogen). Drugs stop hair from growing by forcing it out of the growing phase too early. It is known as telogen effluvium and causes more hair than usual to fall out. Medications damage the root of the hair in the growth stage, leading to faster and more noticeable hair loss, a process called anagen effluvium. Common types of drugs that cause the effects include chemotherapy drugs, antibiotics, antidepressants, and blood pressure medicines. The type and amount of medication affect how much hair is lost.

Medications cause hair loss because they affect hormone levels in the body. Hormones help control how hair grows, and when medications change hormone balance, hair growth slows down or stops. Birth control pills, hormone therapy, thyroid medications, and steroids are examples that affect hormones (estrogen, testosterone, or thyroid hormones). The hair follicles shrink, stop producing new hair, or release hair too early when the levels shift. It leads to thinning hair or bald spots. Hair grows back after stopping the medication or correcting the hormone imbalance, but it takes a few months to return to normal.

Is It Possible to Stop Hair Loss while Taking Necessary Medicines?

Yes, it is possible to stop hair loss while taking the necessary medicines by managing the underlying causes without interrupting critical treatment. Medication-related hair loss results from altered follicle cycling, reduced nutrient absorption, or hormone shifts. Patients taking drugs (metoprolol, phentermine, isotretinoin) face a situation where stopping the medication risk their health. Supportive therapies (topical minoxidil, platelet-rich plasma (PRP), low-level laser therapy) help reduce hair shedding and promote follicle health. Treatment must be individualized under medical supervision to avoid worsening the primary condition.

Stopping medication without guidance leads to serious consequences, any adjustments must involve a physician. Dermatologists recommend switching to an alternative drug with fewer follicular effects or introducing protective treatments to prevent loss. Nutritional correction with iron, zinc, biotin, and amino acids supports new hair growth in cases where hair follicles remain active. Hormone-related hair thinning responds to dihydrotestosterone (DHT) blockers or endocrine balancing strategies. Hair preservation is achievable even while continuing treatment, with early intervention and medical cooperation.

Does Hair Regrowth Begin After Stopping Medications?
Yes, hair regrowth begins after stopping medications because hair follicles return to their normal growth cycle once the drug’s effect is removed. Most drug-induced hair loss is temporary, and regrowth starts within 2 to 6 months if the follicle remains intact. Full recovery depends on the medication, treatment duration, and health factors.

What Types of Hair Loss Can Be Caused by Medications?

Types of Hair Loss can be Caused by Medications are listed below.

• Telogen Effluvium: Telogen effluvium occurs when medications push hair follicles into the resting (telogen) phase too early, causing increased daily shedding. It begins 2 to 3 months after starting the drug and affects the entire scalp rather than forming bald patches. Common triggers include antidepressants, blood pressure drugs, and antibiotics.
• Anagen Effluvium: Anagen effluvium results from medications that disrupt hair growth in the active (anagen) phase by damaging rapidly dividing cells in the follicle. Hair loss is sudden, widespread, and occurs within days to weeks of drug exposure. It is most commonly linked to chemotherapy agents and radiation treatments.

1. Telogen Effluvium

Telogen Effluvium is a type of diffuse, non-scarring alopecia caused by premature transition of anagen (growth-phase) hair follicles into the telogen (resting) phase. 85 to 90% of scalp hairs remain in anagen while 10 to 15% are in telogen under normal conditions, but telogen effluvium shifts the balance, leading to increased daily hair shedding. Medications act as physiological stressors that disrupt follicular cycling through metabolic interference, inflammation, or hormonal imbalance. Onset occurs 2-3 months after exposure, and shedding lasts for 2-3 weeks. Clinical presentation involves diffuse thinning without clear bald patches, with hair regrowing once the trigger is removed.

Drug classes implicated in telogen effluvium include anticoagulants (warfarin, heparin), retinoids (isotretinoin), beta-blockers (metoprolol, propranolol), anticonvulsants (valproic acid, carbamazepine), and antidepressants (fluoxetine, amitriptyline). The agents impair nutrient delivery, hormonal regulation, or keratinocyte turnover in hair follicles, prompting telogen shift. Medication-induced telogen effluvium is reversible once the drug is discontinued, according to “Culprits in medication-induced telogen effluvium” by Zhang, Choi, and Ayoade 2023, with regrowth beginning in 3 to 6 months. The study highlights that over 30 drug categories have been linked to telogen effluvium, with psychotropic, dermatologic, and cardiovascular medications among the most reported.

2. Anagen Effluvium

Anagen Effluvium is a sudden, nonscarring alopecia characterized by the rapid shedding of actively growing (anagen‑phase) hairs. Cytotoxic medications induce mitotic arrest in follicular matrix keratinocytes, producing dystrophic hairs with tapered, fragile shafts prone to breakage. Trichomalacia, which is the breakdown and damage of the hair bulb, causes sudden and widespread hair loss within days to weeks. The condition is triggered by antineoplastic (cancer-fighting) drugs, including alkylating agents, antimetabolites, vinca alkaloids, and topoisomerase inhibitors. It disrupts the active growth phase of hair known as anagen. Chemotherapy drugs (doxorubicin, cyclophosphamide, paclitaxel, methotrexate, daunorubicin, bleomycin) are implicated. Clinical evaluation of 384 cancer‑therapy patients showed that anagen effluvium occurred in 78.6 % of cases. Highest severity noted with doxorubicin, nitrosoureas, and cyclophosphamide. Non‑chemotherapeutic agents (colchicine, gold compounds) and heavy metal toxins rarely induce similar follicular arrest, according to “Anagen effluvium” overview by StatPearls 2021.

How to Stop Hair Loss from Medications

To Stop Hair Loss from Medications, follow the ten steps listed below.

1. Consult a doctor. Ask a healthcare provider to confirm if the medication is the true cause of the hair loss. A professional adjusts the dose or suggests a safer alternative.
2. Adjust the dosage. Lower the dose to reduce the medication’s effect on hair follicle function and minimize shedding. Follow a doctor’s guidance when changing prescribed amounts.
3. Switch medications. Request a switch to another drug in the same category that has fewer hair-related side effects. Classes have multiple options with different follicular effects.
4. Use topical treatments. Apply minoxidil to stimulate blood flow and prolong the hair growth phase. It helps counteract shedding caused by drug-induced telogen effluvium.
5. Improve nutrition. Boost intake of protein, iron, zinc, and B vitamins to support healthy follicles. Malnutrition from medication side effects worsens hair loss.
6. Manage stress levels. Reduce physical and emotional stress through sleep, relaxation, or therapy. Stress intensifies hair shedding and delays regrowth.
7. Add supplements. Take doctor-approved supplements (biotin or collagen) to strengthen hair. Supplements support regrowth when hair loss is linked to nutrient loss.
8. Limit heat and chemicals. Avoid hair dyes, bleach, and excessive styling that weaken already fragile strands. Protecting the scalp prevents further breakage.
9. Try laser therapy. Use low-level laser devices to stimulate hair follicles and increase circulation. The laser therapy is one of the best Hair Loss Treatment methods helps in cases of ongoing thinning.
10. Track medication side effects. Keep a journal to monitor when hair loss begins and how it changes with treatment. It helps doctors make informed changes in therapy.

Medication-related hair loss is temporary and reverses after stopping or adjusting the drug. Permanent loss is rare and occurs only with long-term damage to hair follicles. Early action improves the chance of full regrowth. 

How Effective Is Hair Transplant for Permanent Hair Loss due to Medications?

Hair Transplant for permanent hair loss due to Medications is effective when follicular damage is irreversible and natural regrowth is no longer possible. Drug-induced hair loss is temporary, but in rare cases, after long-term use of chemotherapy agents, immunosuppressants, or hormonal treatments, hair follicles become dormant or scarred, resulting in permanent alopecia. Transplantation becomes a viable solution once the patient has discontinued the medication and stabilized their health. Hair transplant surgery involves harvesting healthy follicles from the back of the scalp and implanting them into areas where the follicles no longer function.

The procedure restores natural hair density and is successful when the donor area remains unaffected by drug exposure. Turkey is known for its advanced medical infrastructure and affordability, making it a global hub for cosmetic surgery. Vera Clinic stands out as the best hair transplant clinic in Turkey, among the leading providers, offering advanced techniques, Follicular Unit Extraction (FUE), and Direct Hair Implantation (DHI) with high success rates. Patients suffering from permanent medication-related hair loss benefit from a Hair Transplant as a long-term, cosmetic restoration solution.

What to Expect Before and After a Hair Transplant Due to Hair Loss from Medications?

Expect scalp mapping before and follicle regrowth and healing progress after a hair transplant due to hair loss from medications. Patients undergo a detailed consultation to confirm that hair loss is permanent and no longer influenced by active medication use. Trichologists and transplant surgeons assess the donor area’s viability, rule out active scalp conditions, and create a customized graft plan based on the hairline design and follicle density needed. Blood tests and scalp photography are performed to document the pre-transplant condition.

Post-surgery, mild swelling and scabbing occur within the first week, followed by a temporary shedding phase called “shock loss,” where transplanted hairs fall out before regrowth begins. New hair emerges between 3 to 6 months, with full results visible after 12 months as follicles fully mature. Final density and texture depend on graft survival and overall scalp health. Patients must review Hair Transplant Before and After cases based on drug-related alopecia, for visual comparison and realistic expectations.

When to See a Dermatologist for Hair Loss due to Medicines

See a Dermatologist for hair loss due to medicines when hair shedding becomes rapid, diffuse, and persistent within days or weeks of starting a new medication. Sudden thinning of the scalp, visible hair clumps on pillows or in the shower, and loss of eyebrows or body hair suggest anagen effluvium, a severe form of drug-induced hair loss. Scalp tenderness, itching, or inflammation accompany follicular damage and indicate the need for immediate evaluation to prevent scarring or permanent alopecia.

Prolonged shedding beyond 8 to 12 weeks, thinning resistant to topical treatments, or a family history of pattern baldness signal compounding conditions that require professional intervention. Dermatologists conduct trichoscopy, pull tests, and scalp biopsies to confirm diagnosis and identify reversible causes. Treatment planning includes medical therapies or a Hair Transplant Consultation for surgical restoration, if irreversible loss is confirmed.

When to Take a Hair Analysis for Hair Loss due to Medicines

Take a hair analysis for hair loss due to medicines if shedding becomes sudden, widespread, and affects more than 30% of scalp coverage within a short period. Anagen effluvium presents with rapid loss of growing hairs that break close to the scalp surface, leading to patchy or diffuse baldness. A detailed hair analysis helps assess structural damage and follicular health in cases where hair shafts appear fragile, thin, or club-shaped under visual inspection. Microscopic evaluation confirms if drug toxicity is disrupting matrix cell division or triggering inflammatory responses in the hair bulb.

Hair analysis becomes essential when standard lab tests fail to explain the cause or when multiple medications are involved. A trichogram or scalp biopsy reveals the growth phase ratio, keratin integrity, and the presence of dystrophic hairs, offering diagnostic clarity. Dermatologists rely on hair shaft examination to differentiate between anagen effluvium and other non-scarring alopecias. Early diagnostic testing supports timely intervention and improves treatment outcomes.

How Is Hair Loss Caused by Medicines Diagnosed?

The things that Caused Hair Loss by Medicines Diagnosed are listed below. 

• Assessing Clinical History: Doctors begin by reviewing the patient’s recent medication use, timeline of hair loss onset, and presence of other systemic symptoms. Hair shedding occurs within days to weeks after exposure to cytotoxic agents, in anagen effluvium. The history helps link the hair loss to a specific drug and rules out other medical causes.
• Physical Examination: A dermatologist examines the scalp for signs of inflammation, scarring, or follicular dropout. Hair loss appears diffuse without clear bald patches, and broken hairs are visible at the scalp surface. The exam helps differentiate between scarring and non-scarring alopecia types.
• Trichoscopy: Trichoscopy is a non-invasive imaging method using a dermatoscope to magnify scalp and hair shaft structures. It reveals yellow dots, broken hairs, and tapered or “exclamation mark” hairs that signal rapid follicular arrest. Trichoscopy is used when visual confirmation is needed without performing a biopsy.
• Hair Shaft Analysis: Microscopic analysis of plucked hairs identifies anagen hairs with misshapen bulbs and fragmented shafts. It is common in chemotherapy-induced hair loss, where dystrophic anagen hairs break easily. Hair shaft analysis helps confirm that the loss originates in the growth phase.

Scalp Biopsy: A 4-mm punch biopsy provides a detailed view of the follicular architecture and hair cycle phase distribution. Biopsy shows a high percentage of damaged anagen follicles with reduced mitotic activity and keratinocyte degeneration. It is reserved for unclear cases when other tests are inconclusive.